Suppr超能文献

解析滤泡性淋巴瘤向弥漫性大 B 细胞淋巴瘤的转化。

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.

机构信息

Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.

Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),Madrid, Spain.

出版信息

PLoS One. 2019 Feb 25;14(2):e0212813. doi: 10.1371/journal.pone.0212813. eCollection 2019.

Abstract

Follicular lymphoma (FL) is an indolent but largely incurable disease. Some patients suffer histological transformation to a more aggressive subtype with poorer prognosis. This study aimed to improve our understanding of the genetics underlying FL histological transformation, and to identify genetic drivers or promoters of the transformation by elucidating the differences between FL samples from patients who did and did not transform. We conducted targeted massive parallel sequencing of 22 pre-transformed FL/transformed diffuse large B-cell lymphoma pairs and 20 diagnostic samples from non-transformed FL patients. Additionally, 22 matched samples from 11 transformed FL patients (pre-transformed FL and diffuse large B-cell lymphoma) and 9 non-transformed FLs were studied for copy number variation using SNP arrays. We identified recurrently mutated genes that were enriched at transformation, most notably LRP1B, GNA13 and POU2AF1, which have roles in B-cell differentiation, GC architecture and migration. Mutations in POU2AF1 might be associated with lower levels of expression, were more frequent in transformed FLs, and seemed to be specific to transformed- compared with de novo-diffuse large B-cell lymphomas. Pre-transformed FLs carried more mutations per sample and had greater subclonal heterogeneity than non-transformed FLs. Finally, we identified four mutated genes in FL samples that differed between patients who did and did not transform: NOTCH2, DTX1, UBE2A and HIST1H1E. The presence of mutations in these genes was associated with shorter time to transformation when mutated in the FL biopsies. This information might be useful for identifying patients at higher risk of transformation.

摘要

滤泡性淋巴瘤(FL)是一种惰性但基本上无法治愈的疾病。一些患者会发生组织学转化,转化为侵袭性更强、预后更差的亚型。本研究旨在深入了解 FL 组织学转化的遗传学基础,并通过阐明未转化和已转化的 FL 样本之间的差异,确定转化的遗传驱动因子或促进因子。我们对 22 对未经转化的 FL/转化弥漫性大 B 细胞淋巴瘤和 20 例非转化 FL 患者的诊断样本进行了靶向大规模平行测序。此外,对 11 例经转化的 FL 患者(未经转化的 FL 和弥漫性大 B 细胞淋巴瘤)的 22 个匹配样本和 9 例非转化 FL 的 SNP 芯片进行了拷贝数变异研究。我们鉴定了在转化过程中富集的高频突变基因,特别是 LRP1B、GNA13 和 POU2AF1,它们在 B 细胞分化、GC 结构和迁移中发挥作用。POU2AF1 中的突变可能与表达水平降低有关,在转化的 FL 中更为频繁,而且似乎是转化性弥漫性大 B 细胞淋巴瘤特有的,而不是新发弥漫性大 B 细胞淋巴瘤。与非转化的 FL 相比,未经转化的 FL 每个样本携带更多的突变,具有更大的亚克隆异质性。最后,我们在 FL 样本中发现了 4 个在未转化和已转化患者之间存在差异的突变基因:NOTCH2、DTX1、UBE2A 和 HIST1H1E。当这些基因在 FL 活检中发生突变时,存在突变与向转化的时间较短有关。这些信息可能有助于识别具有更高转化风险的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e2/6388933/717a7367808e/pone.0212813.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验